HCA Holdings (HCA) PT Lowered to $82 at Piper Jaffray Following 3Q

Go back to HCA Holdings (HCA) PT Lowered to $82 at Piper Jaffray Following 3Q

Credit Suisse Assumes HCA Holdings (HCA) at Outperform

November 3, 2017 2:26 AM EDT

Credit Suisse assumes coverage on HCA Holdings (NYSE: HCA) with a Outperform rating and a price target of $95.00.

For an analyst ratings summary and ratings history on HCA Holdings click here. For more ratings news on HCA Holdings click here.

Shares of HCA Holdings closed at $76.43 yesterday.

... More

HCA Holdings (HCA) PT Lowered to $79 at Morgan Stanley

November 1, 2017 8:55 AM EDT

Morgan Stanley lowered its price target on HCA Holdings (NYSE: HCA) to $79.00 (from $85.00) while maintaining a Equalweight rating.

... More

HCA Holdings (HCA) PT Lowered to $88 at Jefferies; Reiterates Buy

November 1, 2017 8:24 AM EDT

Jefferies lowered its price target on HCA Holdings (NYSE: HCA) to $88.00 (from $90.00) while maintaining a Buy rating. Jefferies expects continued M&A activity that will enable management to achieve their LT EBITDA growth target of +4-6%. That said, analyst Brian Tanquilut believes HCA's... More

HCA Holdings (HCA) Misses Q3 EPS by 72c, Miss on Revenues; FY17 EPS Outlook Below Consensus

October 31, 2017 8:33 AM EDT

HCA Holdings (NYSE: HCA) reported Q3 EPS of $1.21, $0.72 worse than the analyst estimate of $1.93. Revenue for the quarter came in at $10.7 billion versus the consensus estimate of $11.13 billion.

Key third quarter metrics (all percentage changes compare 3Q 2017 to 3Q 2016 unless noted):

Revenues increased 4.2 percent to $10.696 billionNet income attributable to HCA Healthcare, Inc. totaled $426 million, or $1.15 per diluted shareAdjusted EBITDA totaled... More